Annual Current Liabilities
$19.65 M
+$4.38 M+28.73%
31 December 2023
Summary:
Black Diamond Therapeutics annual total current liabilities is currently $19.65 million, with the most recent change of +$4.38 million (+28.73%) on 31 December 2023. During the last 3 years, it has risen by +$5.43 million (+38.18%). BDTX annual current liabilities is now -16.90% below its all-time high of $23.64 million, reached on 31 December 2021.BDTX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$20.80 M
+$2.36 M+12.80%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly total current liabilities is currently $20.80 million, with the most recent change of +$2.36 million (+12.80%) on 30 September 2024. Over the past year, it has increased by +$5.73 million (+38.06%). BDTX quarterly current liabilities is now -21.10% below its all-time high of $26.36 million, reached on 30 September 2021.BDTX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +28.7% | +38.1% |
3 y3 years | +38.2% | -21.1% |
5 y5 years | +663.0% | +347.6% |
BDTX Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -16.9% | +38.2% | -21.1% | +61.9% |
5 y | 5 years | -16.9% | +663.0% | -21.1% | +347.6% |
alltime | all time | -16.9% | +781.0% | -21.1% | +707.8% |
Black Diamond Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $20.80 M(+12.8%) |
June 2024 | - | $18.44 M(+9.4%) |
Mar 2024 | - | $16.85 M(-14.2%) |
Dec 2023 | $19.65 M(+28.7%) | $19.65 M(+30.4%) |
Sept 2023 | - | $15.07 M(+8.4%) |
June 2023 | - | $13.90 M(+8.2%) |
Mar 2023 | - | $12.85 M(-15.8%) |
Dec 2022 | $15.26 M(-35.4%) | $15.26 M(-27.8%) |
Sept 2022 | - | $21.14 M(+7.3%) |
June 2022 | - | $19.71 M(+1.2%) |
Mar 2022 | - | $19.47 M(-17.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $23.64 M(+66.3%) | $23.64 M(-10.3%) |
Sept 2021 | - | $26.36 M(+12.2%) |
June 2021 | - | $23.49 M(+25.6%) |
Mar 2021 | - | $18.70 M(+31.6%) |
Dec 2020 | $14.22 M(+192.4%) | $14.22 M(+25.4%) |
Sept 2020 | - | $11.34 M(+84.7%) |
June 2020 | - | $6.14 M(-15.9%) |
Mar 2020 | - | $7.30 M(+50.1%) |
Dec 2019 | $4.86 M(+88.9%) | $4.86 M(+4.6%) |
Sept 2019 | - | $4.65 M(+80.5%) |
Dec 2018 | $2.58 M(+15.5%) | $2.58 M |
Dec 2017 | $2.23 M | - |
FAQ
- What is Black Diamond Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual current liabilities year-on-year change?
- What is Black Diamond Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly current liabilities year-on-year change?
What is Black Diamond Therapeutics annual total current liabilities?
The current annual current liabilities of BDTX is $19.65 M
What is the all time high annual current liabilities for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual total current liabilities is $23.64 M
What is Black Diamond Therapeutics annual current liabilities year-on-year change?
Over the past year, BDTX annual total current liabilities has changed by +$4.38 M (+28.73%)
What is Black Diamond Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of BDTX is $20.80 M
What is the all time high quarterly current liabilities for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly total current liabilities is $26.36 M
What is Black Diamond Therapeutics quarterly current liabilities year-on-year change?
Over the past year, BDTX quarterly total current liabilities has changed by +$5.73 M (+38.06%)